BD Oncomark™ CD7/CD33 - SFDA Registration ME0000002814SFDAA00176
Access comprehensive regulatory information for BD Oncomark™ CD7/CD33 in the Saudi Arabia medical device market through Pure Global AI's free database. This General IVD(Others) device is registered with Saudi Arabia SFDA under registration number ME0000002814SFDAA00176 and manufactured by Becton, Dickinson and Company, BD Biosciences.
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Anti CD7 and anti CD33 for flow cytometer
BD Oncomark™ CD7 FITC/CD33 PE is intended for in vitro flow cytometric immunophenotyping. This reagent combination can be used to study expression of the CD7 antigen in myeloid lineages. CD33 is useful in identifying myeloid lineage cells.1 CD7, normally expressed in T and natural killer (NK) cells, is frequently aberrantly expressed in acute myeloid leukemia (AML), and could be used in the diagnosis of these diseases.2-6 CD7/CD33 assays are used in the diagnosis of hematologic disorders
[]